ICAM1 and uterine cervix neoplasm: Additionally, to confirm that immune activation (such as the IFN signaling pathway) is indeed induced by I-DXd treatment rather than ICAM1 antibody, we analyzed the potential signaling transductions in human cervical tumors by ICAM1 neutralizing antibody using RNA transcriptomic analyses.